INTRODUCTION
Inflammation has been suggested to affect skeletal muscle metabolism. 1, 2 Results from rat models show that infusion of interleukin-6 or tumour necrosis factor-a reduces muscle protein synthesis, increases skeletal muscle breakdown, [3] [4] [5] as well as alters resting membrane potential of skeletal muscle [4] [5] [6] and decreases contractile functions, 7 which supports the notion of inflammation induced muscle weakness. Skeletal muscle weakness is a wellknown phenomenon in critically ill patients, which is believed to result partly from endotoxemia and inflammatory cytokines. 8 Similarly, in healthy elderly, systemic low-grade inflammation has been implicated in the aetiology of decreased muscle strength, 5 which in turn correlates with functional decline and disability. 9 Age and sex are the main biological determinants of muscle strength both in healthy and sick individuals. 10, 11 In disease, several factors may interact on muscle strength. Bed rest, 12, 13 muscle disuse, 14 corticosteroids and stress, 15, 16 muscle relaxants, hypoxia as well as oxidative stress all have adverse effects on muscle function. 8 Impaired muscle strength in turn has major consequences affecting functional status, recovery and outcome. It is therefore not surprising that reduced muscle strength assessed by handgrip is an excellent predictor of outcome in the clinical setting. Low handgrip strength is a predictor of decreased physical status, increased postoperative complications, increased length of hospital stay and higher rehospitalization rate. 17 In the epidemiological setting, low grip strength in healthy adults predicts increased risk of functional limitations and disability in higher age as well as all-cause mortality. 18, 19 In this large cross-sectional study, we investigated whether C-reactive protein (CRP) as indicator of (acute) inflammation is associated with maximal isometric handgrip strength in non-critically ill patients.
MATERIALS AND METHODS Patients
Six hundred and twenty patients were consecutively recruited at the Department of Gastroenterology, Infectiology and Rheumatology at the University Hospital Charite. Patients were assessed within 48 h of admission to hospital. Patients suffering from critical illness (that is, undergoing intermediate or intensive care), patients under the age of 18 years or with neuromuscular disease, hemiplegia and osteoarthritis were a priori not considered for inclusion due to bias in handgrip strength measurements.
All patients gave written informed consent and the Ethics Committee of the Charite Universitätsmedizin Berlin approved the study. Demographic characteristics, age and sex, clinical variables such as diagnosis and comorbidities as well as length of hospital stay were recorded. As the study population suffered from a wide range of primary diseases including both malignant and benign conditions, comorbidity count was expressed as simple number of relevant additional entities. measured with a portable stadiometer (Seca 220 telescopic measuring rod) to the nearest 0.1 cm. Weight and height were used to calculate body mass index (BMI) (weight [kg]/height [m] 2 ).
Body composition
Bioelectrical impedance analysis was performed using a Nutriguard M (Data Input GmbH, Darmstadt, Germany) applying alternating electric currents of 800 mA at 50 kHz. Patients were measured in the morning after an overnight fast, in the supine position with arms and legs abducted from the body. Source and sensor electrodes were placed on the dorsum of both hand and foot of the dominant side of the body. Fat free mass (FFM) was then calculated according to the formula by Kyle. 20 Maximal isometric skeletal muscle strength
Handgrip strength as indicator of muscle strength of the upper extremities was measured in the nondominant hand with a Jamar dynamometer (Sammons Preston Rolyan, Chicago, IL, USA). The patients performed the test while sitting comfortably with shoulder adducted and neutrally rotated forearm, elbow flexed to 901, and forearm and wrist in neutral position. The patients were instructed to perform a maximal isometric contraction. The test was repeated within 30 s and the highest value of three tests was used for the analysis.
Inflammation
Serum levels of CRP as indicator of inflammation were determined by immunoturbidimetric assay.
Statistics
Statistical analysis was carried out using the software package SPSS Statistics 19, IBM (Armonk, NY, USA). All data are given as mean and s.d. Box plots displaying minimum, maximum and 25th, 50th as well as 75th percentiles were used to portray handgrip strength according to inflammation category. Pearson's correlation was calculated to assess the relationship between variables. Student's t-test was used to compare mean values between groups.
In order to assess the association between CRP as a linear factor and grip strength adjusted for confounders, a regression analysis was performed with the general linear model allowing adjustment for continuous and categorical variables.
The general linear model was repeated with CRP as a categorical factor (groups: no or low-grade inflammation: o10 mg/l, mild inflammation: between 10 and 50 mg/l, moderate inflammation: between 50 and 100 mg/l and severe inflammation: 4100 mg/l).
The following variables were included as known risk factors or potential confounders in both analyses: the biological determinants age (continuous) and sex (male/female), FFM (continuous), BMI (continuous), comorbidity count (continuous) and diagnosis category (benign/malignant, in case of tumour disease). An acceptable level of statistical significance was established a priori at Po0.05.
RESULTS
Six hundred and twenty patients (whereof 324 men, 52.3%) were included (see Table 1 ). Mean age was 56.4±15.9 years, mean BMI was 24.1±4.8 kg/m 2 . Two hundred and sixty patients (41.9%) had malignant disease, whereof 32.2% suffered from gastrointestinal cancer, 20.6% had head and neck cancer, 16% haematological disease, 12.7% had urogenital or breast cancer, 7% had lung cancer and 11.5% other types of malignancies. The majority of patients with benign disease were suffering from hepatic disease (35.5%), 34.7% from inflammatory bowel disease, 11.3% from benign colon disease (diverticulitis), 3.6 from gastric disease, 4.5% from biliary disease, 2.6% from pancreatic disease and 7.8% from other benign diseases.
Mean CRP was 34.2±48.9 mg/l and ranged from 0.20 to 338.2 mg/l; 38.2% of patients had values above 10 mg/l indicating some degree of inflammation. 11.8% had values above 50 mg/l and 8.7% had high CRP levels, above 100 mg/l. Patients with malignant disease had higher CRP values than patients with benign disease (49.4±63.7 vs 23.2±30.1 mg/l, Po0.0001).
Mean handgrip strength was 28.1±11.4 kg and ranged from 10 to 73 kg.
CRP was inversely but only weakly associated with handgrip strength (all: À 0.211. P ¼ 0.003) but did not correlate with age, BMI or FFM. In contrast, handgrip strength correlated strongly with FFM (r ¼ 0.644, Po0.0001), weakly with BMI (r ¼ 0.133, P ¼ 0.01) and negatively with age (r ¼ À 0.303, Po0.0001). Figure 1 shows grip strength stratified according to patients groups with different stages of inflammation.
The general linear model regression analysis corrected for confounding variables revealed a significant independent association of CRP and grip strength (see Table 2 ). When employing CRP as a categorical variable, all groups with signs of inflammation (mild, moderate and severe inflammation) showed significant reduction in handgrip strength compared with patients without elevated levels of CRP (see Table 3 ).
DISCUSSION
In this large cross-sectional cohort of hospitalized, non-critically ill patients, we observed a significant association between CRP as marker of acute inflammation and maximal isometric handgrip strength, which was independent from age, sex, FFM, BMI, comorbidity count and malignancy of disease. Decreased handgrip strength values were already evident in patients who exhibited signs of mild inflammation (that is, CRP levels between 10 and 50 mg/l) corresponding to a loss of 1.6 kg, whereas handgrip strength was lower by 3.2 kg in patients with moderate inflammation and lower by 2.9 kg in patients with very high CRP levels when compared with patients with low CRP levels (see Table 3 ). The correlation between inflammation and muscle weakness is well reported in patients with critical illness, sepsis and multiple organ failure, 2, 8, 21 and also in the healthy elderly as well as geriatric patients in whom low-grade inflammatory CRP values correlate with decreased muscle strength and functional capacity. 5, 22 In acute or chronic respiratory disease, diaphragm weakness, for example, is one major cause of dyspnoea and correlates with increased mortality. 23 Animal models have shown that acute pulmonary inflammation induced by lipopolysaccharide instillation leads to increased diaphragm protein breakdown and subsequent diaphragm atrophy. 24 An association between skeletal muscle wasting, parameters of functional capacity, ventilatory limitation and inflammation has also been found in patients with chronic obstructive pulmonary disease. 25 A negative correlation between CRP and working physical capacity has been reported and likewise interleukin-6 has been shown to be an independent predictor of reduced exercise capacity in patients with COPD. 26, 27 The relationship between acute inflammation assessed by CRP and grip strength in the non-critically ill has hitherto not been thoroughly investigated. In this mixed cohort of hospitalized patients, we have now shown that even mild inflammation has an impact on grip strength when compared with patients with low levels of CRP (o10 mg/l).
Handgrip strength correlates well with functional status and quality of life. 11 Reduced grip strength is also a predictor of impaired short term outcome, such as increased postoperative complications, increased length of hospitalization, higher rehospitalization rate and decreased physical status. 17 Crosssectional data have even demonstrated that low grip strength in healthy adults predicts increased long term risk of functional limitations and disability as well as all-cause mortality in higher age, 18, 28 whereas high grip strength appears to be protective against premature mortality, particularly in men. 19, 29 Our findings merit attention as we have previously shown that control patients released from hospital who are not treated with nutritional or physical therapy do not increase their muscle strength after 3 months despite medical treatment and reduction of CRP values. 30 It is therefore tempting to speculate that although even mild inflammation contributes to reduced grip strength in disease, restoration of muscle strength following disease needs active therapy.
Although limited due to the cross-sectional nature, our data demonstrate the association between even mild acute inflammation and handgrip strength in hospitalized but not critically ill patients. If not corrected, reduced strength may have serious implications for the patients' functional status and prognosis. Every effort should therefore be taken to ensure physical rehabilitation after disease and hospital stay. 
